Emergent BioSolutions Inc. (EBS) Stock Analysis

Free AI-powered analysis and research for Emergent BioSolutions Inc. stock

Sector: Healthcare

Analyze Emergent BioSolutions Inc. (EBS) Stock

Emergent BioSolutions Inc. (EBS) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into EBS stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Emergent BioSolutions Inc. stock.

Analyze EBS Now →

📰 Latest Update

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Mon, June 29, 2026 at 1:13 PM UTC 3 min read

Emergent BioSolutions has announced a contract modification worth approximately $52.7 million from the U.S. government for its ACAM2000® smallpox and mpox vaccine. This development underscores the company's ongoing role in public health preparedness and could enhance its revenue stability. For investors, this contract highlights the potential for continued government partnerships and demand for its vaccine products, which may positively impact future earnings.

Read full article →